Article Details
Retrieved on: 2024-02-05 20:36:13
Tags for this article:
Click the tags to see associated articles and topics
Summary
Immix Biopharma Inc., a clinical-stage biopharma company, plans a public stock offering to fund clinical trials and other corporate activities, pending market conditions and SEC regulations, which include filing a prospectus.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here